CONNECT WITH US
HealthTech

HealthTech

Boston Scientific names Joseph Fitzgerald as chief operating officer

MedTech Dive logo

Published on

Add as a preferred source on Google
Boston Scientific names Joseph Fitzgerald as chief operating officer

Fitzgerald will oversee three newly established reportable segments as Boston Scientific works to bounce back from guidance cuts.

Boston Scientific said Wednesday that it will promote Joseph Fitzgerald to chief operating officer at the start of next year.

Fitzgerald will oversee the company’s global operations, business units and regions. In connection with the appointment, Boston Scientific will establish three reportable segments, each with its own leader who will report to Fitzgerald.

Lance Bates will lead the “Interventional Therapies” segment. Boston Scientific will include Penumbra, the blood-clot removal company it is buying for $14.5 billion, in Bates’ segment. The executive’s current title is president of interventional therapies at Boston Scientific.

Nick Spadea-Anello will oversee the “Rhythm Solutions” segment. Spadea-Anello is currently president of atrial fibrillation solutions at Boston Scientific. Stephen Morse, currently president of Asia Pacific at Boston Scientific, will lead the “MedSurg” segment.

Boston Scientific CEO Mike Mahoney outlined the rationale for the move to three reportable segments.

“These changes reflect the scale and breadth of our business today and the opportunities ahead,” Mahoney said in a statement. “The new operating model will create greater capacity to focus on our long-term growth priorities while enabling our businesses to move faster and remain close to our customers and their patients.”

The changes follow a period in which Boston Scientific cut its sales guidance two quarters in a row, began a restructuring that could cost up to $800 million and experienced a cyberattack that disrupted its ability to make devices and process orders.


Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.